{
  "id": 461712,
  "title": "Axsome Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update",
  "url": "https://urgent.news/2026/08/10/axsome-therapeutics-reports-second-quarter-2026-financial-results-and",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-10T11:04:45.000Z",
  "source": {
    "name": "Financial Post",
    "slug": "financial-post",
    "url": "https://financialpost.com/globe-newswire/axsome-therapeutics-reports-second-quarter-2026-financial-results-and-provides-business-update"
  },
  "original_language": "en",
  "account": null,
  "summary": "Total 2Q 2026 net product revenue of $218.4 million, representing 46% year-over-year growth AUVELITY® 2Q 2026 net product sales of $180.3 million, representing 51% year-over-year growth SUNOSI® 2Q 2026 net product revenue of $35.8 million, representing 20% year-over-year growth SYMBRAVO® 2Q 2026 net product sales of $2.3 million AUVELITY launched for treatment of agitation associated […]",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Financial Post",
        "title": "Nexus Industrial REIT Announces Second Quarter 2026 Financial Results",
        "url": "https://urgent.news/2026/08/10/nexus-industrial-reit-announces-second-quarter-2026-financial-results",
        "published": "2026-08-10T21:40:23.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}